methylphenidate has been researched along with Affective Psychosis, Bipolar in 63 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the short-term efficacy of methylphenidate in the treatment of youths with bipolar disorder (BD) and comorbid attention deficit/hyperactivity disorder (ADHD)." | 9.12 | Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. ( Calabrese, JR; Demeter, CA; Findling, RL; Gracious, BL; Manos, MJ; McNamara, NK; Short, EJ; Stansbrey, RJ; Whipkey, R, 2007) |
| "The authors sought to determine the risk of treatment-emergent mania associated with methylphenidate, used in monotherapy or with a concomitant mood-stabilizing medication, in patients with bipolar disorder." | 7.85 | The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder. ( Almqvist, C; Chang, Z; D'Onofrio, BM; Landén, M; Larsson, H; Lichtenstein, P; Lundholm, C; Magnusson, PK; Rydén, E; Thase, ME; Viktorin, A, 2017) |
| "Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)." | 7.73 | Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006) |
| " We conducted a randomized crossover trial with MPH and placebo (2 weeks each) combined with aripiprazole in children and adolescents (n = 16; 8-17 years old) with JBPD and ADHD who had a significant response in manic symptoms with aripiprazole but still presented clinically significant symptoms of ADHD." | 6.74 | Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. ( Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP, 2009) |
| "Methylphenidate is a stimulant medication that is sometimes used as an antidepressant in bipolar adults and is frequently used in children with comorbid bipolar and attention-deficit disorder." | 5.33 | Naturalistic long-term use of methylphenidate in bipolar disorder. ( El-Mallakh, RS; Lydon, E, 2006) |
| "Gabapentin is an anticonvulsant drug released in the United States in 1993 for use as adjunctive therapy in refractory partial epilepsy." | 5.31 | Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. ( Bailey, K; Hamrin, V, 2001) |
| "To examine the short-term efficacy of methylphenidate in the treatment of youths with bipolar disorder (BD) and comorbid attention deficit/hyperactivity disorder (ADHD)." | 5.12 | Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. ( Calabrese, JR; Demeter, CA; Findling, RL; Gracious, BL; Manos, MJ; McNamara, NK; Short, EJ; Stansbrey, RJ; Whipkey, R, 2007) |
| "The use of traditional psychostimulants (methylphenidate and dexamphetamine) and stimulant-like drugs (modafinil and armodafinil) for the treatment of depression is a growing concern given the lack of research evidence supporting their effectiveness." | 4.93 | Stimulants for depression: On the up and up? ( Bassett, D; Boyce, P; Byrow, Y; Hopwood, M; Lyndon, W; Malhi, GS; Mulder, R; Murray, G; Porter, R; Singh, A, 2016) |
| "Medication with methylphenidate should be avoided in patients with vulnerability to schizophrenia and in drug addiction, but reported cases without these risk factors demonstrate that a careful and regular psychiatric monitoring is essential in all patients treated with methylphenidate." | 4.86 | Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. ( Kis, B; Kraemer, M; Uekermann, J; Wiltfang, J, 2010) |
| "The authors sought to determine the risk of treatment-emergent mania associated with methylphenidate, used in monotherapy or with a concomitant mood-stabilizing medication, in patients with bipolar disorder." | 3.85 | The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder. ( Almqvist, C; Chang, Z; D'Onofrio, BM; Landén, M; Larsson, H; Lichtenstein, P; Lundholm, C; Magnusson, PK; Rydén, E; Thase, ME; Viktorin, A, 2017) |
| "In this study, we aimed to evaluate the relationship between attention-deficit/hyperactivity disorder (ADHD) during childhood and subsequent diagnoses of bipolar disorder (BD), as well as to determine whether the pharmacotherapy for ADHD (methylphenidate and atomoxetine) influence the risks of developing BD." | 3.83 | Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan. ( Lee, SY; Lee, TL; Shyu, YC; Wang, LJ; Yang, CJ; Yang, KC; Yuan, SS, 2016) |
| "Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)." | 3.73 | Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006) |
| "This study used data from a completed longitudinal study to examine the effects of methylphenidate on 6-12-year-old boys presumably at risk for bipolar disorder." | 3.70 | Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study. ( Arthur, C; Carlson, GA; Kramer, JR; Loney, J; Salisbury, H, 2000) |
| " In view of increasing interest in the therapeutic potential of carbamazepine (CBZ) in bipolar disorder, we examined the effect of CBZ pretreatment on methylphenidate-induced behavioral activation and euphoria." | 3.67 | Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment. ( Bow, J; Gershon, S; Lerer, B; Meyendorff, E; Moore, NC, 1985) |
| " We conducted a randomized crossover trial with MPH and placebo (2 weeks each) combined with aripiprazole in children and adolescents (n = 16; 8-17 years old) with JBPD and ADHD who had a significant response in manic symptoms with aripiprazole but still presented clinically significant symptoms of ADHD." | 2.74 | Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial. ( Ketzer, CR; Pheula, GF; Rohde, LA; Tramontina, S; Zeni, CP, 2009) |
| "Some evidence indicates that bipolar depression may be more responsive to dopaminergic agents, suggesting that adjunctive stimulant medication may be an effective treatment for bipolar depression as well as for medication-induced sedation." | 2.71 | Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation. ( Carlson, PJ; Merlock, MC; Suppes, T, 2004) |
| "Methylphenidate has been advocated as an effective antidepressant agent in unipolar depression, and depression secondary to medical illness." | 2.69 | An open study of methylphenidate in bipolar depression. ( El-Mallakh, RS, 2000) |
| "Moreover, the use of antidepressants in bipolar depression is controversial due to concerns regarding the risks of inefficacy or switching to mood elevation." | 2.49 | Use of adjunctive stimulants in adult bipolar depression. ( Dell'Osso, B; Ketter, TA, 2013) |
| "Carvone is a monoterpene that is present in spearmint (Mentha spicata) and caraway (Carum carvi) essential oils and has been shown to have anticonvulsant effects, likely through the blockade of voltage-gated sodium channels, and anxiolytic-like effects." | 1.43 | Antimanic-like effects of (R)-(-)-carvone and (S)-(+)-carvone in mice. ( Andreatini, R; Barcaro, IM; de Sousa, DP; Nogoceke, FP, 2016) |
| "The treatment with methylphenidate (10mg/kg, ip) increased locomotion in the open field test." | 1.43 | Lithium and valproate prevent methylphenidate-induced mania-like behaviors in the hole board test. ( Asth, L; Gavioli, EC; Lobão-Soares, B; Medeiros, IU; Santos, WB; Silva, EF; Soares-Rachetti, VP; Souza, LS, 2016) |
| "Carbamazepine was used as a positive control." | 1.39 | The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels. ( Andreatini, R; Biojone, C; Casarotto, PC; Correia, D; Guimarães, FS; Joca, SL; Martynhak, BJ; Pereira, M; Siba, IP; Tonelli, DA, 2013) |
| "Methylphenidate is a stimulant medication that is sometimes used as an antidepressant in bipolar adults and is frequently used in children with comorbid bipolar and attention-deficit disorder." | 1.33 | Naturalistic long-term use of methylphenidate in bipolar disorder. ( El-Mallakh, RS; Lydon, E, 2006) |
| "Gabapentin is an anticonvulsant drug released in the United States in 1993 for use as adjunctive therapy in refractory partial epilepsy." | 1.31 | Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder. ( Bailey, K; Hamrin, V, 2001) |
| "Patients with unipolar depression were studied in a drug-free baseline state following short-term administration of methylphenidate and in a euthymic state in long-term follow-up." | 1.27 | Positron emission tomographic study of affective disorders: problems and strategies. ( Baxter, L; Gerner, R; Mazziotta, JC; Phelps, ME, 1984) |
| "Depression is an important cause of behavioral disturbances in children." | 1.26 | Childhood depression: an explanation of a behavior disorder of children. ( Brumback, RA; Weinberg, WA, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (28.57) | 18.7374 |
| 1990's | 1 (1.59) | 18.2507 |
| 2000's | 18 (28.57) | 29.6817 |
| 2010's | 22 (34.92) | 24.3611 |
| 2020's | 4 (6.35) | 2.80 |
| Authors | Studies |
|---|---|
| Asth, L | 2 |
| Tiago, PRF | 1 |
| Costa, LRF | 1 |
| Holanda, VAD | 1 |
| Pacifico, S | 1 |
| Zaveri, NT | 1 |
| Calo', G | 1 |
| Ruzza, C | 1 |
| Gavioli, EC | 2 |
| Gomes-Pereira, E | 1 |
| Covelo, V | 1 |
| Reis, C | 1 |
| Friedrich, B | 1 |
| Bridler, R | 1 |
| Rohde, C | 1 |
| Salagre, E | 1 |
| Nielsen, J | 1 |
| Østergaard, SD | 1 |
| Ketter, TA | 2 |
| Dell'Osso, B | 2 |
| Zhu, S | 1 |
| Cordner, ZA | 1 |
| Xiong, J | 1 |
| Chiu, CT | 1 |
| Artola, A | 1 |
| Zuo, Y | 1 |
| Nelson, AD | 1 |
| Kim, TY | 1 |
| Zaika, N | 1 |
| Woolums, BM | 1 |
| Hess, EJ | 1 |
| Wang, X | 1 |
| Chuang, DM | 1 |
| Pletnikov, MM | 1 |
| Jenkins, PM | 1 |
| Tamashiro, KL | 1 |
| Ross, CA | 1 |
| Hegerl, U | 2 |
| Mergl, R | 2 |
| Sander, C | 2 |
| Dietzel, J | 2 |
| Bitter, I | 2 |
| Demyttenaere, K | 2 |
| Gusmão, R | 2 |
| González-Pinto, A | 2 |
| Zorrilla, I | 1 |
| Alocén, AG | 1 |
| Sola, VP | 1 |
| Vieta, E | 2 |
| Juckel, G | 2 |
| Zimmermann, US | 2 |
| Bauer, M | 2 |
| Sienaert, P | 2 |
| Quintão, S | 2 |
| Edel, MA | 2 |
| Bolyos, C | 2 |
| Ayuso-Mateos, JL | 2 |
| López-García, P | 2 |
| Kluge, M | 2 |
| Tonelli, DA | 1 |
| Pereira, M | 1 |
| Siba, IP | 1 |
| Martynhak, BJ | 1 |
| Correia, D | 1 |
| Casarotto, PC | 1 |
| Biojone, C | 1 |
| Guimarães, FS | 1 |
| Joca, SL | 1 |
| Andreatini, R | 3 |
| Perez-Sola, V | 1 |
| Parker, G | 2 |
| Brotchie, H | 2 |
| McClure, G | 1 |
| Fletcher, K | 1 |
| Rubia, K | 1 |
| Alegría, AA | 1 |
| Brinson, H | 1 |
| Wassef, N | 1 |
| Khan, N | 1 |
| Munir, S | 1 |
| Wang, LJ | 1 |
| Shyu, YC | 1 |
| Yuan, SS | 1 |
| Yang, CJ | 1 |
| Yang, KC | 1 |
| Lee, TL | 1 |
| Lee, SY | 1 |
| Laurito, LD | 1 |
| Fontenelle, LF | 1 |
| Kahn, DA | 1 |
| Malhi, GS | 1 |
| Byrow, Y | 1 |
| Bassett, D | 1 |
| Boyce, P | 1 |
| Hopwood, M | 1 |
| Lyndon, W | 1 |
| Mulder, R | 1 |
| Porter, R | 1 |
| Singh, A | 1 |
| Murray, G | 1 |
| Nogoceke, FP | 1 |
| Barcaro, IM | 1 |
| de Sousa, DP | 1 |
| Souza, LS | 1 |
| Silva, EF | 1 |
| Santos, WB | 1 |
| Lobão-Soares, B | 1 |
| Soares-Rachetti, VP | 1 |
| Medeiros, IU | 1 |
| Viktorin, A | 1 |
| Rydén, E | 1 |
| Thase, ME | 1 |
| Chang, Z | 1 |
| Lundholm, C | 1 |
| D'Onofrio, BM | 1 |
| Almqvist, C | 1 |
| Magnusson, PK | 1 |
| Lichtenstein, P | 1 |
| Larsson, H | 1 |
| Landén, M | 1 |
| Mattingly, GW | 1 |
| Anderson, RH | 1 |
| Kummer, A | 1 |
| Teixeira, A | 1 |
| Wagner, KD | 1 |
| Atmaca, M | 1 |
| Ozler, S | 1 |
| Topuz, M | 1 |
| Goldstein, S | 1 |
| Zeni, CP | 1 |
| Tramontina, S | 1 |
| Ketzer, CR | 1 |
| Pheula, GF | 1 |
| Rohde, LA | 1 |
| McLaren, JL | 1 |
| Cauble, S | 1 |
| Barnett, RJ | 1 |
| Rothermel, B | 1 |
| Poustka, L | 1 |
| Banaschewski, T | 1 |
| Becker, K | 1 |
| Park, YM | 1 |
| Jung, YK | 1 |
| Kraemer, M | 1 |
| Uekermann, J | 1 |
| Wiltfang, J | 1 |
| Kis, B | 1 |
| Barbosa, FJ | 1 |
| Hesse, B | 1 |
| de Almeida, RB | 1 |
| Baretta, IP | 1 |
| Boerngen-Lacerda, R | 1 |
| Kowatch, RA | 1 |
| Sethuraman, G | 1 |
| Hume, JH | 1 |
| Kromelis, M | 1 |
| Weinberg, WA | 2 |
| Galanter, CA | 1 |
| Carlson, GA | 3 |
| Jensen, PS | 1 |
| Greenhill, LL | 1 |
| Davies, M | 1 |
| Li, W | 1 |
| Chuang, SZ | 1 |
| Elliott, GR | 1 |
| Arnold, LE | 1 |
| March, JS | 1 |
| Hechtman, L | 1 |
| Pelham, WE | 1 |
| Swanson, JM | 1 |
| MORGAN, DR | 1 |
| Carlson, PJ | 1 |
| Merlock, MC | 1 |
| Suppes, T | 1 |
| Benjamin, E | 1 |
| Salek, S | 1 |
| Jaworowski, S | 1 |
| Benarroch, F | 1 |
| Gross-Tsur, V | 1 |
| Ross, RG | 1 |
| Lydon, E | 1 |
| El-Mallakh, RS | 2 |
| Sharp, BW | 1 |
| Tahiroglu, AY | 1 |
| Avci, A | 1 |
| Findling, RL | 1 |
| Short, EJ | 1 |
| McNamara, NK | 1 |
| Demeter, CA | 1 |
| Stansbrey, RJ | 1 |
| Gracious, BL | 1 |
| Whipkey, R | 1 |
| Manos, MJ | 1 |
| Calabrese, JR | 1 |
| Janowsky, DS | 4 |
| Judd, LL | 1 |
| Huey, LY | 1 |
| Risch, SC | 1 |
| Segal, DS | 1 |
| Phelps, ME | 1 |
| Mazziotta, JC | 1 |
| Baxter, L | 1 |
| Gerner, R | 1 |
| Bannet, J | 1 |
| Ebstein, RP | 2 |
| Belmaker, RH | 2 |
| Loney, J | 1 |
| Salisbury, H | 1 |
| Kramer, JR | 1 |
| Arthur, C | 1 |
| Bschor, T | 1 |
| Müller-Oerlinghausen, B | 1 |
| Ulrich, G | 1 |
| Hamrin, V | 1 |
| Bailey, K | 1 |
| Davis, JM | 4 |
| Kadouch, R | 1 |
| Peres, L | 1 |
| Leichner, P | 1 |
| Parker, D | 1 |
| Judd, L | 1 |
| Huey, L | 1 |
| Clopton, P | 1 |
| Brown, WA | 1 |
| Mueller, B | 1 |
| Bloomingdale, LM | 1 |
| Bressler, B | 1 |
| Meyers, B | 1 |
| Brumback, RA | 1 |
| Gershon, S | 2 |
| Angrist, B | 1 |
| Shopsin, B | 1 |
| Rapport, MD | 1 |
| Kelly, KL | 1 |
| Pataki, CS | 1 |
| Schmidt, K | 1 |
| Delaney, MA | 1 |
| Jensen, M | 1 |
| Levinson, DF | 1 |
| Lewitt, M | 1 |
| Koehler-Troy, C | 1 |
| Strober, M | 1 |
| Malenbaum, R | 1 |
| Meyendorff, E | 1 |
| Lerer, B | 1 |
| Moore, NC | 1 |
| Bow, J | 1 |
| el-Yousel, MK | 1 |
| Sekerke, HJ | 2 |
| el-Yousef, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| International Randomised Double-blind Placebo-controlled Study on the Initial Treatment of Acute Mania With Methylphenidate[NCT01541605] | Phase 3 | 42 participants (Actual) | Interventional | 2012-03-31 | Completed | ||
| Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD: A Randomized Cross-Over Placebo Controlled Trial[NCT00305370] | Phase 4 | 20 participants (Anticipated) | Interventional | 2005-08-31 | Completed | ||
| Multimodal Treatment Study of Children With ADHD[NCT00000388] | Phase 4 | 0 participants | Interventional | 1998-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for methylphenidate and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Brain abnormalities in attention-deficit hyperactivity disorder: a review.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; A | 2014 |
Stimulants for depression: On the up and up?
Topics: Amphetamine; Antidepressive Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System S | 2016 |
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine H | 2016 |
Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimu | 2010 |
Use of adjunctive stimulants in adult bipolar depression.
Topics: Adult; Antipsychotic Agents; Benzhydryl Compounds; Bipolar Disorder; Central Nervous System Stimulan | 2013 |
Behavioral effects of opioid receptor antagonists in psychopathologic states.
Topics: Affective Disorders, Psychotic; Animals; beta-Endorphin; Bipolar Disorder; Clinical Trials as Topic; | 1983 |
12 trials available for methylphenidate and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study).
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; | 2018 |
Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Female; Humans; Male; | 2013 |
Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bipol | 2009 |
Combination pharmacotherapy in children and adolescents with bipolar disorder.
Topics: Adolescent; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorde | 2003 |
Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
Topics: Adult; Aged; Amphetamine; Antipsychotic Agents; Bipolar Disorder; Central Nervous System Stimulants; | 2004 |
Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System | 2007 |
Behavioral effects of opioid receptor antagonists in psychopathologic states.
Topics: Affective Disorders, Psychotic; Animals; beta-Endorphin; Bipolar Disorder; Clinical Trials as Topic; | 1983 |
An open study of methylphenidate in bipolar depression.
Topics: Adult; Amphetamines; Antidepressive Agents; Bipolar Disorder; Drug Therapy, Combination; Female; Fol | 2000 |
The effect of methylphenidate on serum growth hormone: influence of antipsychotic drugs and diagnosis.
Topics: Adjustment Disorders; Adolescent; Adult; Alcoholism; Antipsychotic Agents; Bipolar Disorder; Blood P | 1978 |
Alleviation of manic symptoms with catecholamine agonists.
Topics: Apomorphine; Bipolar Disorder; Clinical Trials as Topic; Dextroamphetamine; Double-Blind Method; Hum | 1979 |
The effects of methylphenidate and lithium on attention and activity level.
Topics: Arousal; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Drug Therapy, Combi | 1992 |
Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.
Topics: Adolescent; Adult; Bipolar Disorder; Brain Chemistry; Chlorpromazine; Clinical Trials as Topic; Dopa | 1973 |
46 other studies available for methylphenidate and Affective Psychosis, Bipolar
| Article | Year |
|---|---|
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Female; Hyperkinesis; Imidazoles; Methylphenidate; Mice | 2020 |
Methylphenidate as a short-term adjunct therapy in bipolar depression - case report.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Male; Methylpheni | 2020 |
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Humans; Mania; Methylphenidate; Moo | 2020 |
Use of methylphenidate and the incidence of intentional self-harm or suicide attempts among individuals with schizophrenia, bipolar disorder and personality disorder.
Topics: Bipolar Disorder; Humans; Incidence; Methylphenidate; Personality Disorders; Schizophrenia; Self-Inj | 2021 |
Commentary on the Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; | 2017 |
Genetic disruption of ankyrin-G in adult mouse forebrain causes cortical synapse alteration and behavior reminiscent of bipolar disorder.
Topics: Animals; Ankyrins; Bipolar Disorder; Disease Models, Animal; GABAergic Neurons; Lithium; Methylpheni | 2017 |
The antimanic-like effect of phenytoin and carbamazepine on methylphenidate-induced hyperlocomotion: role of voltage-gated sodium channels.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Carbamazepine; Disease Models, Animal; Dose-Response Re | 2013 |
Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits.
Topics: Adult; Aged; Aged, 80 and over; Bipolar Disorder; Central Nervous System Stimulants; Cost-Benefit An | 2013 |
Quetiapine-induced myocarditis presenting as acute STEMI.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; C | 2015 |
Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bipolar Disord | 2016 |
Hoarding Symptoms Respond to Treatment for Rapid Cycling Bipolar II Disorder.
Topics: Bipolar Disorder; Calcium Channel Blockers; Depressive Disorder; Dopamine Uptake Inhibitors; Hoardin | 2016 |
Antimanic-like effects of (R)-(-)-carvone and (S)-(+)-carvone in mice.
Topics: Animals; Antimanic Agents; Bipolar Disorder; Cyclohexane Monoterpenes; Male; Methylphenidate; Mice; | 2016 |
Lithium and valproate prevent methylphenidate-induced mania-like behaviors in the hole board test.
Topics: Animals; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Central Nervous System Stimulants; Di | 2016 |
The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Cohort Stu | 2017 |
Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
Topics: Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous Sy | 2008 |
Recognizing parents' symptoms, obesity, and bipolar depression.
Topics: Adolescent; Age Factors; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Di | 2008 |
Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzod | 2009 |
Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
Topics: Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Central Nervous System Stimulants; Depres | 2010 |
Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
Topics: Acute Disease; Antipsychotic Agents; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Bi | 2010 |
[Bipolar disorders as co-morbidity in childhood and adolescence--underdiagnosed or overinterpreted? Therapy of a 14-year-old boy with hyperkinetic conduct disorder and hypomania].
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; A | 2010 |
Manic switch and serotonin syndrome induced by augmentation of paroxetine with methylphenidate in a patient with major depression.
Topics: Adolescent; Bipolar Disorder; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Male; M | 2010 |
Magnesium sulfate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal model of mania.
Topics: Animals; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Central Nervous System Stimulants; Dis | 2011 |
Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Chi-Square Distribution; Child; Dru | 2003 |
Largactil, ritalin and meratran in the treatment of endogenous psychotic depression.
Topics: Bipolar Disorder; Chlorpromazine; Depression; Depressive Disorder, Major; Methylphenidate; Piperidin | 1957 |
Stimulant-atypical antipsychotic interaction and acute dystonia.
Topics: Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar | 2005 |
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi | 2006 |
Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Ne | 2006 |
Naturalistic long-term use of methylphenidate in bipolar disorder.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Attention; Attention Deficit Disorde | 2006 |
Cmap ADHD and comorbid aggression algorithm.
Topics: Aggression; Algorithms; Attention Deficit Disorder with Hyperactivity; Biomedical Research; Bipolar | 2007 |
Polypharmacy and EPS in a child; a case report.
Topics: Attention Deficit Disorder with Hyperactivity; Benztropine; Bipolar Disorder; Child; Comorbidity; Do | 2007 |
Positron emission tomographic study of affective disorders: problems and strategies.
Topics: Bipolar Disorder; Depressive Disorder; Female; Glucose; Humans; Lithium; Male; Methylphenidate; Mood | 1984 |
Clinical aspects of the interaction of lithium and stimulants.
Topics: Bipolar Disorder; Drug Interactions; Humans; Lithium; Male; Methylphenidate; Middle Aged | 1980 |
Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Central Nervous System Stimulants; | 2000 |
Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study.
Topics: Bipolar Disorder; Central Nervous System Stimulants; Electroencephalography; Female; Humans; Male; M | 2001 |
Gabapentin and methylphenidate treatment of a preadolescent with attention deficit hyperactivity disorder and bipolar disorder.
Topics: Acetates; Amines; Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; | 2001 |
Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Diso | 1975 |
Thphenidate.
Topics: Adjustment Disorders; Adrenergic beta-Agonists; Adult; Bipolar Disorder; Blood Pressure; Cyclic AMP; | 1977 |
Rapid intramuscular administration of tricyclic antidepressants.
Topics: Adjustment Disorders; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depr | 1979 |
Treatment of imipramine-resistant depression and lithium-refractory mania through drug interactions.
Topics: Adult; Bipolar Disorder; Chlorothiazide; Diabetes Insipidus; Drug Interactions; Humans; Imipramine; | 1978 |
Childhood depression: an explanation of a behavior disorder of children.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Child; Child Behavior Disorders; Depression; Dex | 1977 |
Drugs, diagnosis, and disease.
Topics: Acetylcholine; Amphetamines; Bipolar Disorder; Humans; Imipramine; Levodopa; Lithium; Methylphenidat | 1975 |
Methylphenidate challenge in a manic boy.
Topics: Bipolar Disorder; Child; Humans; Male; Methylphenidate | 1986 |
Methylphenidate-induced mania in a prepubertal child.
Topics: Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Child Behavior Disorders; Hu | 1986 |
Methylphenidate infusion in euthymic bipolars: effect of carbamazepine pretreatment.
Topics: Adult; Arousal; Bipolar Disorder; Carbamazepine; Euphoria; Female; Humans; Infusions, Parenteral; Ma | 1985 |
A two factor theory of schizophrenia.
Topics: Acetylcholine; Amphetamine; Animals; Bipolar Disorder; Brain; Dextroamphetamine; Dopamine; Dose-Resp | 1974 |
Antagonistic effects of physostigmine and methylphenidate in man.
Topics: Affective Symptoms; Behavior; Bipolar Disorder; Humans; Inhibition, Psychological; Methylphenidate; | 1973 |